This inventor holds 1 USPTO granted patent. Top assignee: Peking University. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Innovations of Linjie Tian in Biopharmaceuticals
Introduction
Linjie Tian is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of polypeptide fragments that have therapeutic applications. His work is crucial in addressing various medical conditions, including HIV infection and autoimmune diseases.
Latest Patents
Linjie Tian holds a patent for "Polypeptide fragments of CKLF1." This patent discloses polypeptides that have an amino acid sequence of SEQ ID NO: 2, specifically focusing on amino acid residues 9 to 27 of SEQ ID NO: 2, collectively referred to as C-terminal polypeptides of CKLF1. The patent also includes a pharmaceutical composition containing a therapeutically effective amount of the CKLF1 C-terminal polypeptide along with pharmaceutically acceptable salts, carriers, or excipients. Additionally, it covers polynucleotides encoding these polypeptides, vectors, and host cells containing the polynucleotides. The invention provides in vitro assays for detecting the expression levels of the polypeptide or polynucleotide in test samples, as well as monoclonal or polyclonal antibodies against the polypeptides or their active fragments. The polypeptides can be used pharmaceutically for treating HIV infection, allergic diseases, allograft rejection, brain diseases, and autoimmune diseases. Linjie Tian has 1 patent to his name.
Career Highlights
Linjie Tian is affiliated with Peking University, where he conducts research and develops innovative solutions in the biopharmaceutical sector. His work has garnered attention for its potential impact on treating serious health conditions.
Collaborations
Linjie Tian collaborates with notable colleagues, including Wenling Han and Ying Wang, who contribute to his research endeavors and enhance the scope of his projects.
Conclusion
Linjie Tian's innovative work in the field of biopharmaceuticals exemplifies the importance of research and development in addressing critical health issues. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.